Previous Meetings

GBCC 2022

Global Breast Cancer Conference 2022

08:00-09:15
GBCC-SSO Joint Session
Venue: RM 3(Walker Hall 1)
  • Clinical Trials of Breast Cancer Surgery in Korea & Introduction to KBCSG
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
  • Trials in Breast Cancer Lead by Surgical Oncologists in the US & Introduction to SSO
    Jennifer Plichta (Duke Univ. Medical Center, U.S.A.)
08:30-09:15
Satellite Symposium 2
Novartis
Venue: RM 1(Vista 1+2)
  • The Evolving Landscape of HR+/HER2- Breast Cancer Treatment
    Aditya Bardia (Massachusetts General Hospital, U.S.A.)
09:30-10:15
Plenary Lecture 3
Venue: RM 1(Vista 1+2)
  • Defining Today’s Surgical Standards of Care in Patients with Breast Cancer
    Walter Paul Weber (Univ. Hospital Basel, Switzerland)
10:30-11:45
Symposium 3
Translational Approach through Cancer Genomics and Biology
Venue: RM 1(Vista 1+2)
  • Genomic Amplification Linked to Therapeutic Resistance in Breast Cancer
    Jeong-Yeon Lee (Hanyang Univ. College of Medicine, Korea)
  • Immune Biomarker and Ecosystem in Breast Cancer
    Alex Swarbrick (Garvan Institute of Medical Research, Australia)
  • Genomics Related to Treatment After CDK4/6 Inhibitors in Hormone Receptor Positive Breast Cancer
    Rinath Jeselsohn (Dana-Farber Cancer Institute, U.S.A.)
Panel Discussion 5
Obesity, Life Style Modification, and Exercise
Venue: RM 2(Vista 3)
  • The Role of Weight Loss and Metformin in the Adjuvant Treatment of Breast Cancer
    Pamela Goodwin (Lunenfeld Tanenbaum Research Institute at Sinai Health System, Univ. of Toronto, Canada)
  • Life Style Modification of Breast Cancer Survivors
    Hyun Jo Youn (Jeonbuk National Univ. Hospital, Korea)
  • Physical Activity Intervention in Women with Breast Cancer
    Justin Y. Jeon (Yonsei Cancer Center, Korea)
Education Session 5
Update in the Management of Adverse Events
Venue: RM 3(Walker Hall 1)
  • Management of Cardiotoxicity of Breast Cancer
    Woo-Baek Chung (Seoul St. Mary’s Hospital, Korea)
  • Management of AIMSS (Aromatase-inhibitor-associated Musculoskeletal Syndrome)
    Eun Joo Yang (Daerim St. Mary's Hospital, Korea)
  • Management of Chemotherapy Induced Nausea and Vomiting (CINV)
    Toshiaki Saeki (Saitama Medical Univ. International Medical Center, Japan)
Oral Presentation 3
Venue: RM 4(Walker Hall 2)
ABCN Business Meeting (Invited Only)
Venue: RM 5(Art Hall)
  • Legacy of GBCC: Beyond Asia Towards the World, New Era of GBCC
    Joon Jeong (Gangnam Severance Hospital, Korea)
  • Sharing Wisdom, Sharing Strength - Mentorship and International Collaboration
    Philip Poortmans (Iridium Netwerk & Univ. of Antwerp, Belgium)
  • Knowledge, Attitude, Practice Behaviors and Barriers for Fertility Preservation 
    Heejeong Kim (ASAN Medical Center, Korea)
12:00-12:45
Plenary Lecture 4
Venue: RM 1(Vista 1+2)
  • Optimising Radiation Therapy in Early Stage Breast Cancer
    Philip Poortmans (Iridium Netwerk & Univ. of Antwerp, Belgium)
13:00-13:45
Satellite Symposium 3
Roche Korea
Venue: RM 1(Vista 1+2)
  • Transforming the Treatment Journey for HER2+ Breast Cancer Patients
    Joyce O'Shaughnessy (Baylor Univ. Medical Center, U.S.A.)
14:00-14:45
Plenary Lecture 5
Venue: RM 1(Vista 1+2)
  • Presurgical Window Studies for Drug Development, Studies of Resistance and Patient Management
    Mitch Dowsett (Royal Marsden Hospital, UK)
15:00-16:15
Symposium 4
Immunotherapy in Breast Cancer
Venue: RM 1(Vista 1+2)
  • Current Status of Immunotherapy: Where are We?
    Hiroji Iwata (Aichi Cancer Center Hospital, Japan)
  • Biomarker for Immunotherapy: What is the Best?
    Peter Schmid (Bart's Cancer Institute, UK)
  • Challenge for Immunotherapy in Breast Cancer: Hot or Cold
    Sherene Loi (Univ. of Melbourne, Australia)
Panel Discussion 6
Updates of Combined Management for Metastatic Breast Cancer
Venue: RM 2(Vista 3)
  • Timing of Breast Surgery in Metastatic Breast Cancer: Is It Really Necessary to Perform Palliative Mastectomy?
    Sung Gwe Ahn (Gangnam Severance Hospital, Korea)
  • Current Status of Locoregional Therapy in ER+/HER2- Oligometastatic Breast Cancer
    Takayuki Ueno (The Cancer Institute Hospital of JFCR, Japan)
  • Role of Stereotactic Ablative Radiotherapy in Oligometastatic Breast Cancer
    Steven J. Chmura (Univ. of Chicago, U.S.A.)
Education Session 6
Psychologic Problem Management
Venue: RM 3(Walker Hall 1)
  • Psychological Interventions on Fatigue of Breast Cancer Patients
    Eun-Jung Shim (Pusan National Univ. Hospital, Korea)
  • Assessment and Management of Insomnia
    Seockhoon Chung (ASAN Medical Center, Korea)
  • Standard of Care for Breast Cancer Distress
    Hideko Yamauchi (St. Luke's International Hospital, Japan)
Oral Presentation 4
Venue: RM 4(Walker Hall 2)
Nursing Session 1 (Korean)
Challenges of Nursing Care Beyond a Pandemic
Venue: RM 5(Art Hall)
  • The Education for Breast Cancer Patients During Covid Pandemic
    Jiyoung Choi (Seoul National Univ. Bundang Hospital, Korea)
  • Supportive Care Post Pandemic Breast Cancer Patients
    In Jeong Cho (Wonju Severance Christian Hospital, Korea)
  • Experience of Education for Breast Cancer Patients post COVID-19
    Nayeon Kim (Samsung Medical Center, Korea)
16:30-17:45
Symposium 5
Recent Updates for Surgery After Neoadjuvant Chemotherapy
Venue: RM 1(Vista 1+2)
  • De-escalation of Axillary Surgery After NACT
    Jeong Eon Lee (Samsung Medical Center, Korea)
  • De-escalation of Breast Surgery After NACT
    Peter C. Dubsky (Hirslanden Klinik St. Anna, Switzerland)
  • Can We Select Patients in Whom We Can Forego Any Axillary Treatment after up front Chemotherapy?
    Emiel Rutgers (Netherlands Cancer Institute, Netherlands)
Panel Discussion 7
How to Apply Multigene Panel for ER+ EBC- Asia vs. Western
Venue: RM 2(Vista 3)
  • Multigene Assays: What Evidence Do We Have?
    Janice Tsang (The Univ. of Hong Kong, Hong Kong)
  • Is There any Difference in Multigene Assays Developed from Asian and Western Countries?
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
  • Practical Application of Multigene Assays in Real Clinical Setting (Asia vs. Western)
    Rebecca Dent (National Cancer Centre Singapore, Singapore)
Education Session 7
Tailored Adjuvant Endocrine Therapy in ER+ Breast Cancer
Venue: RM 3(Walker Hall 1)
  • Optimal Treatment Options for High Risk ER+ Breast Cancer
    Maria-Joao Cardoso (Champalimaud Foundation, Portugal)
  • Extended Endocrine Therapy, Optimal Duration and Sequence
    Sung Hoon Sim (National Cancer Center, Korea)
  • Ovarian Suppression with/without Adjuvant Chemotherapy in High-risk Premenopausal Patients
    Shin-Cheh Chen (Chang Gung Memorial Hospital, Taiwan)
Oral Presentation 5
Venue: RM 4(Walker Hall 2)
Nursing Session 2 (Korean)
Return to Life Beyond Cure Among Young Women
Venue: RM 5(Art Hall)
  • Working Young Women with Breast Cancer: For a Life that Makes Me Who I Am
    Ka Ryeong Bae (National Cancer Center, Korea)
  • Human Flourishing in Adolescents and Young Adults with Cancer
    Eunji Cho (Vanderbilt Univ., Korea)
  • Fertility Preservation for Women with Breast Cancer
    Jeehee Han (Chung-Ang Univ. College of Nursing, Korea)
18:00-18:45
Satellite Symposium 4
Lilly Korea
Venue: RM 1(Vista 1+2)
  • Verzenio, Potent CDK4/6 Inhibitor, How to Optimize HR+/HER2- mBC Patient with CDK4/6 Inhibitors
    Tomoyuki Aruga (Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan)
Back to Previous Meetings